Evidence map›Paper›PMID 17898866›Full record

ArticleNeoplasia (New York, N.Y.)2007

Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate.

Noa Matarasso, Anat Bar-Shira, Uri Rozovski, Serena Rosner, Avi Orr-Urtreger

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01545518 (IVIG Treatment for Refractory Immune-Related Adult Epilepsy), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01545518 phase2terminatednot on this mapstarted 2011, after this paper: background citation

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

TypeinterventionalSponsorEmory UniversityRan2011 to 2013Enrolled20ConditionsEpilepsy, Cryptogenic, Epilepsy, Partial, Seizure Disorder, Autoimmune Diseases, Nervous SystemArmsIVIG
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Experimental and therapeutic medicine · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The War on Cancer rages on.Neoplasia (New York, N.Y.) · 2009
    Article
  17. Article
  18. Neoplasia: the second decade.Neoplasia (New York, N.Y.) · 2008
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Noa MatarassoGenetic Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Anat Bar-Shira
Uri Rozovski
Serena Rosner
Avi Orr-Urtreger
Tel Aviv Sourasky Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overexpression of the centrosome-associated serine/threonine kinase Aurora Kinase A (AURKA) has been demonstrated in both advanced prostate cancer and high-grade prostatic intraepithelial neoplasia lesions. The single-nucleotide polymorphism T91A (Phe31Ile) has been implicated in AURKA overexpression and has been suggested as a low-penetrance susceptibility allele in multiple human cancers, including prostate cancer. We studied the transcriptional consequences of the AURKA Ile31 allele in 28 commercial normal prostate tissue RNA samples (median age, 27 years). Significant overexpression of AURKA was demonstrated in homozygous and heterozygous AURKA Ile31 prostate RNA (2.07-fold and 1.93-fold, respectively; P < .05). Expression levels of 1509 genes differentiated between samples homozygous for Phe31 alleles and samples homozygous for Ile31 alleles (P = .05). Gene Ontology classification revealed overrepresentation of cell cycle arrest, ubiquitin cycle, antiapoptosis, and angiogenesis-related genes. When these hypothesis-generating results were subjected to more stringent statistical criteria, overexpression of a novel transcript of the natural killer tumor recognition sequence (NKTR) gene was revealed and validated in homozygous Ile31 samples (2.6-fold; P < .05). In summary, our data suggest an association between the AURKA Ile31 allele and an altered transcriptome in normal non-neoplastic prostates.

Indexed as

Polymorphism, Single NucleotideAdenocarcinomaAdultAgedAllelesAmino Acid SequenceAndrogensAurora Kinase AAurora KinasesBase SequenceCell Line, TumorGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMiddle AgedAndrogensAURKA protein, humanAurora Kinase AAurora KinasesNeoplasm ProteinsProtein IsoformsProtein Serine-Threonine KinasesAurora Kinase AcancerNKTRoverexpressionprostate

Identifiers

PMID17898866
PMCPMC1993855
OpenAlexW2062069253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.